Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.omtn.2018.05.027
Title: Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury
Authors: Dong J. 
Liao W. 
Peh H.Y. 
Tan W.S.D. 
Zhou S.
Wong W.S.F. 
Keywords: chronic obstructive pulmonary disease; cigarette smoke; NF-KB; ribosomal protein S3; siRNA
Issue Date: 2018
Publisher: Cell Press
Citation: Dong J., Liao W., Peh H.Y., Tan W.S.D., Zhou S., Wong W.S.F. (2018). Ribosomal Protein S3 Gene Silencing Protects Against Cigarette Smoke-Induced Acute Lung Injury. Molecular Therapy - Nucleic Acids 12 : 370-380. ScholarBank@NUS Repository. https://doi.org/10.1016/j.omtn.2018.05.027
Abstract: Chronic obstructive pulmonary disease (COPD) is estimated to be the third leading cause of death by 2030. Transcription factor NF-?B may play a critical role in COPD pathogenesis. Ribosomal protein S3 (RPS3), a 40S ribosomal protein essential for executing protein translation, has recently been found to interact with the NF-?B p65 subunit and promote p65 DNA-binding activity. We sought to study whether RPS3 gene silencing could protect against cigarette-smoke (CS)-induced acute lung injury in a mouse model. Effects of an intratracheal RPS3 siRNA in CS-induced lung injury were determined by measuring bronchoalveolar lavage (BAL) fluid cell counts, levels of inflammatory and oxidative damage markers, and NF-?B translocation. Lung RPS3 level was found to be upregulated for the first time with CS exposure, and RPS3 siRNA blocked CS-induced neutrophil counts in BAL fluid. RPS3 siRNA suppressed CS-induced lung inflammatory mediator and oxidative damage marker levels, as well as nuclear p65 accumulation and transcriptional activation. RPS3 siRNA was able to disrupt CS extract (CSE)-induced NF-?B activation in an NF-?B reporter gene assay. We report for the first time that RPS3 gene silencing ameliorated CS-induced acute lung injury, probably via interruption of the NF-?B activity, postulating that RPS3 is a novel therapeutic target for COPD. © 2018 The Authors
Source Title: Molecular Therapy - Nucleic Acids
URI: http://scholarbank.nus.edu.sg/handle/10635/152584
ISSN: 21622531
DOI: 10.1016/j.omtn.2018.05.027
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
j.omtn.2018.05.027.pdf1.84 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

3
checked on Mar 25, 2020

WEB OF SCIENCETM
Citations

1
checked on Jul 17, 2019

Page view(s)

69
checked on Mar 20, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.